PLASMA KALLIKREIN INHIBITORS

The present invention provides a compound of formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CERNAKA, Natalija, BAO, Jianming, TANG, Haiqun, LOPEZ, Jovan Alexander, XIAO, Dong, CHENG, Alan, C, OGAWA, Anthony, K, SHARP, Phillip Patrick
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	CERNAKA, Natalija BAO, Jianming TANG, Haiqun LOPEZ, Jovan Alexander XIAO, Dong CHENG, Alan, C OGAWA, Anthony, K SHARP, Phillip Patrick
description	The present invention provides a compound of formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4308125A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4308125A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4308125A13</originalsourceid><addsrcrecordid>eNrjZJAJ8HEM9nVU8Hb08fH0DnL19FPw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJsYGFoZGpo6GxkQoAQA7SyB4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PLASMA KALLIKREIN INHIBITORS</title><source>esp@cenet</source><creator>CERNAKA, Natalija ; BAO, Jianming ; TANG, Haiqun ; LOPEZ, Jovan Alexander ; XIAO, Dong ; CHENG, Alan, C ; OGAWA, Anthony, K ; SHARP, Phillip Patrick</creator><creatorcontrib>CERNAKA, Natalija ; BAO, Jianming ; TANG, Haiqun ; LOPEZ, Jovan Alexander ; XIAO, Dong ; CHENG, Alan, C ; OGAWA, Anthony, K ; SHARP, Phillip Patrick</creatorcontrib><description>The present invention provides a compound of formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240124&DB=EPODOC&CC=EP&NR=4308125A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240124&DB=EPODOC&CC=EP&NR=4308125A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CERNAKA, Natalija</creatorcontrib><creatorcontrib>BAO, Jianming</creatorcontrib><creatorcontrib>TANG, Haiqun</creatorcontrib><creatorcontrib>LOPEZ, Jovan Alexander</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>CHENG, Alan, C</creatorcontrib><creatorcontrib>OGAWA, Anthony, K</creatorcontrib><creatorcontrib>SHARP, Phillip Patrick</creatorcontrib><title>PLASMA KALLIKREIN INHIBITORS</title><description>The present invention provides a compound of formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJ8HEM9nVU8Hb08fH0DnL19FPw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJsYGFoZGpo6GxkQoAQA7SyB4</recordid><startdate>20240124</startdate><enddate>20240124</enddate><creator>CERNAKA, Natalija</creator><creator>BAO, Jianming</creator><creator>TANG, Haiqun</creator><creator>LOPEZ, Jovan Alexander</creator><creator>XIAO, Dong</creator><creator>CHENG, Alan, C</creator><creator>OGAWA, Anthony, K</creator><creator>SHARP, Phillip Patrick</creator><scope>EVB</scope></search><sort><creationdate>20240124</creationdate><title>PLASMA KALLIKREIN INHIBITORS</title><author>CERNAKA, Natalija ; BAO, Jianming ; TANG, Haiqun ; LOPEZ, Jovan Alexander ; XIAO, Dong ; CHENG, Alan, C ; OGAWA, Anthony, K ; SHARP, Phillip Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4308125A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CERNAKA, Natalija</creatorcontrib><creatorcontrib>BAO, Jianming</creatorcontrib><creatorcontrib>TANG, Haiqun</creatorcontrib><creatorcontrib>LOPEZ, Jovan Alexander</creatorcontrib><creatorcontrib>XIAO, Dong</creatorcontrib><creatorcontrib>CHENG, Alan, C</creatorcontrib><creatorcontrib>OGAWA, Anthony, K</creatorcontrib><creatorcontrib>SHARP, Phillip Patrick</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CERNAKA, Natalija</au><au>BAO, Jianming</au><au>TANG, Haiqun</au><au>LOPEZ, Jovan Alexander</au><au>XIAO, Dong</au><au>CHENG, Alan, C</au><au>OGAWA, Anthony, K</au><au>SHARP, Phillip Patrick</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PLASMA KALLIKREIN INHIBITORS</title><date>2024-01-24</date><risdate>2024</risdate><abstract>The present invention provides a compound of formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre ; ger
recordid	cdi_epo_espacenet_EP4308125A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	PLASMA KALLIKREIN INHIBITORS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T23%3A27%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CERNAKA,%20Natalija&rft.date=2024-01-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4308125A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true